Abstract
In this chapter, an overview of chemically modified antisense oligonucleotides (AON) for Duchenne muscular dystrophy (DMD) treatment is described. In particular, the promising exon-skipping properties of 2′-O-modified phosphorothioate oligoribonucleotides incorporating 2′-O-[2-(N-methycarbamoyl)ethyl]ribonucleosides that could be readily synthesized by new regioselective oxa-Michael reaction are reviewed in detail.
Author supplied keywords
Cite
CITATION STYLE
Masaki, Y., Yamada, T., Saneyoshi, H., Ohkubo, A., Seio, K., & Sekine, M. (2014). Synthesis and Exon-Skipping Activity of Chemically Modified RNAs. In RNA Technologies (pp. 497–510). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-642-54452-1_27
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
